There are 790+ interventional and observational clinical trial records associated with either KRAS itself or the pathway that KRAS is part of. The interventional studies are designed to evaluate the potential treatments including small vaccines, monoclonal antibodies and small molecules. More than 22 small molecule inhibitors with varied specificity against distinct KRAS mutants.
